{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:04:36Z","timestamp":1784646276430,"version":"3.55.0"},"reference-count":24,"publisher":"Society of Nuclear Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Nucl. Med.\n                Technol."],"accepted":{"date-parts":[[2026,5,28]]},"DOI":"10.2967\/jnmt.126.272396","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T14:50:35Z","timestamp":1784645435000},"page":"jnmt.126.272396","source":"Crossref","is-referenced-by-count":0,"title":["Renal Function During and After\n                    <sup>177<\/sup>\n                    Lu-PSMA-617 Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer"],"prefix":"10.2967","author":[{"given":"Kiflom","family":"Gebreslassea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhat","family":"Mansoori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis","family":"Loux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Saghebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razi","family":"Muzaffar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medhat M.","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"2026072107250513000_jnmt.126.272396v1.1","first-page":"17","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin."},{"key":"2026072107250513000_jnmt.126.272396v1.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2011.02799.x"},{"key":"2026072107250513000_jnmt.126.272396v1.3","first-page":"1365","article-title":"Increasing prevalence of metastatic castration-resistant prostate cancer in a managed care population in the United States","volume":"32","author":"Wallace","year":"2021","journal-title":"Cancer Causes Control."},{"key":"2026072107250513000_jnmt.126.272396v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.11.025"},{"key":"2026072107250513000_jnmt.126.272396v1.5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30198-0"},{"key":"2026072107250513000_jnmt.126.272396v1.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107322"},{"key":"2026072107250513000_jnmt.126.272396v1.7","unstructured":"FDA expands Pluvicto\u2019s metastatic castration-resistant prostate cancer indication. U.S. Food and Drug Administration website. https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-expands-pluvictos-metastatic-castration-resistant-prostate-cancer-indication. Published March 28, 2025. Accessed June 25, 2026."},{"key":"2026072107250513000_jnmt.126.272396v1.8","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262713"},{"key":"2026072107250513000_jnmt.126.272396v1.9","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"2026072107250513000_jnmt.126.272396v1.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1114248"},{"key":"2026072107250513000_jnmt.126.272396v1.11","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.261982"},{"key":"2026072107250513000_jnmt.126.272396v1.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0270-9295(03)00093-7"},{"key":"2026072107250513000_jnmt.126.272396v1.13","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.236414"},{"key":"2026072107250513000_jnmt.126.272396v1.14","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262245"},{"key":"2026072107250513000_jnmt.126.272396v1.15","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.eururo.2023.12.004","article-title":"Safety analyses of the phase 3 VISION trial of [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer","volume":"85","author":"Chi","year":"2024","journal-title":"Eur Urol."},{"key":"2026072107250513000_jnmt.126.272396v1.16","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.265448"},{"key":"2026072107250513000_jnmt.126.272396v1.17","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05525-7"},{"key":"2026072107250513000_jnmt.126.272396v1.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-77889-3"},{"key":"2026072107250513000_jnmt.126.272396v1.19","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.265986"},{"key":"2026072107250513000_jnmt.126.272396v1.20","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.267452"},{"key":"2026072107250513000_jnmt.126.272396v1.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00237-3"},{"key":"2026072107250513000_jnmt.126.272396v1.22","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1007\/s00259-026-07893-4","article-title":"Longitudinal renal function following [177Lu]Lu-PSMA I&T in metastatic castration-resistant prostate cancer","volume":"53","author":"Cockcroft","year":"2026","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026072107250513000_jnmt.126.272396v1.23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/pros.24250","article-title":"Pretherapeutic estimated glomerular filtration rate predicts development of chronic kidney disease in patients receiving PSMA-targeted radioligand therapy","volume":"82","author":"Widjaja","year":"2022","journal-title":"Prostate."},{"key":"2026072107250513000_jnmt.126.272396v1.24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.eururo.2022.05.025","article-title":"Extensive 177Lu-PSMA radioligand therapy can lead to radiation nephropathy with a renal thrombotic microangiopathy-like picture","volume":"83","author":"Sch\u00e4fer","year":"2023","journal-title":"Eur Urol."}],"container-title":["Journal of Nuclear Medicine Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnmt.126.272396","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T14:50:37Z","timestamp":1784645437000},"score":1,"resource":{"primary":{"URL":"http:\/\/tech.snmjournals.org\/lookup\/doi\/10.2967\/jnmt.126.272396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":24,"alternative-id":["10.2967\/jnmt.126.272396"],"URL":"https:\/\/doi.org\/10.2967\/jnmt.126.272396","relation":{},"ISSN":["0091-4916","1535-5675"],"issn-type":[{"value":"0091-4916","type":"print"},{"value":"1535-5675","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]}}}